HIF1A and lymphoma: Inhibition of HIF-1α or overexpression of VHL leads to the colony formation inability in the same models, in which the presumed fraction of lymphoma stem cells activates HIF-1α while also increasing Notch expression, suggesting that HIF-1α may represent a potential target for hematological malignancy treatment [125].